age limit for semaglutide Are there restrictions on GLP-1s? Tirzepatide as Compared with Semaglutide

It has been shown to reduce body weight by a mean of 15.2% in overweight/obese patients without diabetes, but with the presence of at least one weight-related comorbidity (hypertension, dyslipidemia, CVD) 28

In contrast, eight of the 10 states with the lowest share of patients on GLP-1s are located in the Western U.S., where obesity prevalence tends to be lower

Over time, the patterns become easier to see

doi:10.1038/s41591-018-0125-4 2023 The Author(s)

For example, the genetic ablation of CD38 increases NAD + levels in brown adipose tissues, enhancing the thermogenic activity of brown adipocytes [67]

Expected Weight Loss Numbers at Different Stages Clinical evidence from GLP-1 receptor agonist trials shows average weight loss of 3-5 pounds in the first month for patients taking semaglutide consistently